Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 26:15:723715.
doi: 10.3389/fnhum.2021.723715. eCollection 2021.

Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment: A Meta-Analysis of Randomized Controlled Trials

Affiliations

Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment: A Meta-Analysis of Randomized Controlled Trials

Xinqi Zhang et al. Front Hum Neurosci. .

Abstract

Background: Mild cognitive impairment (MCI) is an intermediary state between normal aging and dementia. It has a high risk of progression in patients with Alzheimer's disease (AD). Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique used to improve cognitive deficits in patients with MCI and AD. Although previous meta-analyses included studies carried on patients with MCI and AD, few studies have analyzed patients with MCI independently. This meta-analysis aimed to evaluate the effects and safety of rTMS on cognition function in patients with MCI and factors that may influence such effects. Methods: Data used in this study were searched and screened from different databases, including PubMed, Web of Science, Embase, the Cochrane Library, Chinese National Knowledge Infrastructure (CNKI), Chinese Technical Periodicals (VIP), Wanfang Database, and China BioMedical Literature Database (SinoMed). The retrieved studies were carefully reviewed, data were extracted, and the quality of data was assessed. Results: A total of 12 studies involving 329 patients with MCI were included in the present meta-analysis. The analyses results revealed that rTMS improved cognitive function [standardized mean difference (SMD) = 0.83, 95% confidence interval (CI) = 0.44-1.22, p = 0.0009] and memory function (SMD = 0.73, 95% CI = 0.48-0.97, p < 0.00001) in the MCI + rTMS active group when compared to the sham stimulation group. The showed that: (1) cognitive improvement was more pronounced under high-frequency rTMS stimulation of multiple sites, such as the bilateral dorsolateral prefrontal cortex and (2) more than 10 rTMS stimulation sessions produced higher improvement on cognition function in patients with MCI. Conclusions: This study shows that rTMS can improve cognitive function in patients with MCI, especially when applied at high frequency, multi-site, and for a prolonged period. However, further studies are required to validate these findings and explore more effective stimulation protocols and targets. Systematic Review Registration: [http://www.crd.york.ac.uk/PROSPERO/], identifier: CRD 42021238708.

Keywords: cognitive function; intervention; memory; mild cognitive impairment; repetitive transcranial magnetic stimulation; therapy; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
A flow diagram showing the search and inclusion criteria for studies [Based on PRISMA statement (www.prisma-statement.org)]. Other sources from Chou et al. (2020).
Figure 2
Figure 2
Risk of bias summary: review authors' judgments about each risk of bias item for each included study.
Figure 3
Figure 3
Risk of bias graph: the risks of bias of included studies. Based on the Cochrane's handbook.
Figure 4
Figure 4
A forest plot representing the overall outcome of rTMS effect on MCI. Mean differences in the effect of rTMS on the overall outcome of MCI with 95% CI.
Figure 5
Figure 5
A funnel plot showing publication bias among included studies. The funnel plot was plotted with SMD on the X-axis and the standard error on the Y-axis.
Figure 6
Figure 6
A forest plot displaying the effect of rTMS stimulation on the overall cognitive function in MCI. Mean differences in the effect of rTMS on the overall cognitive function in patients with MCI with 95% CI.
Figure 7
Figure 7
A forest plot showing results of subgroup analyses results for memory outcomes. Mean differences in the effect of rTMS on the memory outcomes in patients with MCI with 95% CI.
Figure 8
Figure 8
A forest plot showing results of subgroup analyses for stimulation sites (single site vs. multiple sites). Mean differences in stimulation sites subgroup with 95% CI.
Figure 9
Figure 9
A forest plot showing results of subgroup analyses results for the number of stimulation treatments (>10 vs. ≤10 treatments). Mean differences in stimulation numbers subgroup with 95% CI.
Figure 10
Figure 10
A forest plot displaying results of subgroup analyses results for adverse effects.

References

    1. Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. . (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
    1. Alcalá-Lozano R., Morelos-Santana E., Cortés-Sotres J. F., Garza-Villarreal E. A., Sosa-Ortiz A. L., González-Olvera J. J. (2018). Similar clinical improvement and maintenance after rTMS at 5 Hz using a simple vs. complex protocol in Alzheimer's disease. Brain Stimul. 11, 625–627. 10.1016/j.brs.2017.12.011 - DOI - PubMed
    1. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington: American Psychiatric Association.
    1. Anderkova L., Eliasova I., Marecek R., Janousova E., Rektorova I. (2015). Distinct pattern of gray matter atrophy in mild Alzheimer's disease impacts on cognitive outcomes of noninvasive brain stimulation. J. Alzheimers Dis. 48, 251–260. 10.3233/JAD-150067 - DOI - PubMed
    1. Birks J., Flicker L. (2006). Donepezil for mild cognitive impairment. Cochrane Database Syst. Rev. 3:CD006104. 10.1002/14651858.CD006104 - DOI - PubMed

Publication types

LinkOut - more resources